ArticleClinical oral investigations2025
Screening for objective indicators in pulp blood to distinguish the degree of pulpitis.
Article in Clinical oral investigations, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThis study aimed to (1) evaluate the accuracy of pulp blood color parameters-L* (brightness) and a* (red chroma)-in assessing the clinical severity of pulp inflammation; (2) identify key biomarkers in pulp blood associated with pulp inflammation degree. MATERIALS AND
methodsTeeth in clinical cases were categorized into four groups based on pre-operative diagnosis and intra-operative microscopic evaluation of the dentine, exposed pulp tissue, and bleeding. Group 1 included intact teeth with normal pulp as the control group. Groups 2, 3 and 4 were teeth with carious pulp exposure: Group 2 exhibited no signs of infection in the pulp tissue or surrounding dentine; Group 3 exhibited infected pulp tissue or dentin surrounding the exposure that was confined to the coronal portion; and Group 4 had infected pulp tissue extending into the radicular pulp. Pulp blood samples were obtained from pulp exposure sites of above teeth. After centrifugation, twenty inflammatory biomarkers in the supernatant of pulp blood were quantified using a multiplex immunoassay. Color parameters (L* and a*) of the residual pulp blood samples were measured using a spectrophotometer. One-way ANOVA was used to compare the L* and a* values across groups. The Kruskal-Wallis test was used to compare biomarker levels. The level of significance was set at 2-tailed P < 0.05.
resultsA total of 97 cases were included in the final analysis: Group 1 (n = 25), Group 2 (n = 17), Group 3 (n = 25) and Group 4 (n = 30). With increasing clinical inflammation severity from Groups 1 to 4, the L* value of pulp blood significantly decreased, while the a* value increased (P < 0.05). Compared to Group 1, the levels of MMP-9, IL-1β, osteoactivin, OPN, IL-8 and the IL-8/IL-10 and IL-6/IL-10 ratios in pulp blood were significantly higher in Group 2, 3 and 4 (P < 0.05), while the levels of TGF-β1 presented with the opposite trend (P < 0.01).
conclusionsColor characteristics and molecular biomarkers in pulp blood could serve as objective indicators for assessing pulp inflammation degree and may further provide a basis for selecting vital pulp therapy strategies. CLINICAL RELEVANCE: These findings have the potential to enhance the diagnostic accuracy of pulpitis and support clinical decision-making in vital pulp therapy, ultimately improving clinical outcomes and tooth survival.
Indexed as
Identifiers
41162777What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.